Precigen (PGEN) Goodwill & Intangibles (2012 - 2026)
Precigen (PGEN) reported Goodwill & Intangibles of $18.1 million for Q1 2026, down 22.25% year-over-year from $23.3 million in Q1 2025, and down 1.73% quarter-over-quarter from $18.4 million in Q4 2025.
Precigen (PGEN) Goodwill & Intangibles (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Goodwill & Intangibles data on file, last reported at $18.1 million in Q1 2026.
- Goodwill & Intangibles for Q1 2026 came in at $18.1 million, down 22.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.1 million (down 22.25% YoY), and the FY2025 annual result was $18.4 million, down 21.95% from the prior year.
- Goodwill & Intangibles declined to $18.1 million in Q1 2026 per PGEN's latest filing, from $18.4 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $105.0 million in Q1 2022 and troughed at $18.1 million in Q1 2026.
- A 5-year average of $52.9 million and a median of $65.3 million in 2024 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles rose 12.45% in 2022, then sank 64.95% in 2024.
- A 5-year view of Goodwill & Intangibles shows it stood at $81.4 million in 2022, then slipped by 17.28% to $67.3 million in 2023, then slumped by 64.95% to $23.6 million in 2024, then decreased by 21.95% to $18.4 million in 2025, then decreased by 1.73% to $18.1 million in 2026.
- Business Quant data shows PGEN's Goodwill & Intangibles at $18.1 million in Q1 2026, $18.4 million in Q4 2025, and $18.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.10 Mn |
| Dec 31, 2025 | 18.41 Mn |
| Sep 30, 2025 | 18.73 Mn |
| Jun 30, 2025 | 19.05 Mn |
| Mar 31, 2025 | 23.28 Mn |
| Dec 31, 2024 | 23.59 Mn |
| Sep 30, 2024 | 29.69 Mn |
| Jun 30, 2024 | 30.01 Mn |
| Mar 31, 2024 | 65.27 Mn |
| Dec 31, 2023 | 67.31 Mn |
| Sep 30, 2023 | 77.32 Mn |
| Jun 30, 2023 | 79.62 Mn |
| Mar 31, 2023 | 80.81 Mn |
| Dec 31, 2022 | 81.38 Mn |
| Sep 30, 2022 | 79.13 Mn |
| Jun 30, 2022 | 82.80 Mn |
| Mar 31, 2022 | 105.04 Mn |
| Dec 31, 2021 | 72.37 Mn |
| Sep 30, 2021 | 111.12 Mn |
| Jun 30, 2021 | 114.22 Mn |